Gevo (NASDAQ:GEVO) Files An 8-K Regulation FD DisclosureItem 9.01. Regulation FD Disclosure.
As of June 28, 2018, the Company had cash and cash equivalents of approximately $27.3 million.
This amount is unaudited and preliminary, and does not present all information necessary for an understanding of the Company’s financial condition as of June 28, 2018. The Company’s estimate is based solely on information available to it as of June 28, 2018. Actual results for the quarter ending June 30, 2018 remain subject to the completion of management’s and the Company’s audit committee’s final reviews and the Company’s other financial closing procedures and the completion of the preparation of the Company’s unaudited consolidated financial statements.
Item 9.01.Other Events.
Exercise of Series K Warrants
During June 2018, the Company received notices of exercise from holders of its Series K warrants to purchase common stock (the “Series K Warrants”) to issue an aggregate of 299,823 shares of common stock for total gross proceeds of approximately $1.36 million. Following these exercises, Series K Warrants to purchase 4,677 shares of common stock remain outstanding at an exercise price of $4.20 per share.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits.
|
ExhibitNo. |
Description |
|
1.1 |
At-The-Market Offering Agreement, dated February 13, 2018, between Gevo, Inc. and H.C. Wainwright & Co., LLC (incorporated by reference to Exhibit 1.1 of the Current Report on Form 8-K filed on February 13, 2018). |
|
1.2 |
Amendment to At-The-Market Offering Agreement and Engagement Agreement, dated June 20, 2018, between Gevo, Inc. and H.C. Wainwright & Co., LLC. |
|
1.3 |
Amendment to At-The-Market Offering Agreement, dated June 25, 2018, between Gevo, Inc. and H.C. Wainwright & Co., LLC (incorporated by reference to Exhibit 1.3 of the Current Report on Form 8-K filed on June 25, 2018). |
Gevo, Inc. ExhibitEX-1.4 2 ex_117005.htm EXHIBIT 1.4 ex_117005.htm Exhibit 1.4 June 28,…To view the full exhibit click here
About Gevo (NASDAQ:GEVO)
Gevo, Inc. (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.
